Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704. - Wikidata - wikimedia - TriplyDB

Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.

Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.

http://www.wikidata.org/entity/Q37445933

about

Double-Hit Large B Cell Lymphoma.Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis.

P2860

Q45304558-F2851696-206E-4552-9AD2-E9C7372F3C70 Q55510639-BDD9FAC9-AB0C-4F2A-A0E8-238619E29F56

P2860

Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.

http://www.wikidata.org/entity/Q37445933

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Outcomes of MYC-associated lym ...... d trial intergroup SWOG S9704.

@en

Outcomes of MYC-associated lym ...... d trial intergroup SWOG S9704.

@nl

type

label

Outcomes of MYC-associated lym ...... d trial intergroup SWOG S9704.

@en

Outcomes of MYC-associated lym ...... d trial intergroup SWOG S9704.

@nl

prefLabel

Outcomes of MYC-associated lym ...... d trial intergroup SWOG S9704.

@en

Outcomes of MYC-associated lym ...... d trial intergroup SWOG S9704.

@nl

P1433

Q37445933-312836E9-B2B1-46BC-B8B2-2A207EE9516A

P1476

Q37445933-8B7AAB69-C4F2-4B53-B391-91194C2522F8

P2093

Q37445933-097987EA-BCD9-446F-89F4-56E4361AB4D5

Q37445933-1D194646-BDA0-4583-BAC1-E8DEF6B8C34E

Q37445933-282F33E5-CB6E-4BD4-BF8A-201C1DE48BBA

Q37445933-62BD3C99-B21C-478A-BC4C-F36B9F22AC08

Q37445933-6BCC52AD-073E-4844-8A71-F7B3D3EF0F51

Q37445933-6E6C8408-3B2A-43C0-8607-A4E61EA75E74

Q37445933-7CB11A33-461E-49AC-95DD-D86BBE3ACE78

Q37445933-8746AF3B-0C4D-40E2-A83A-6880BD58ADCF

Q37445933-A40AD853-9B6C-4BFF-B98C-B859D2D4FA62

Q37445933-AB59F30B-80BE-465E-8326-4D775F514B6B

P2860

Q37445933-1D8F6DAF-01C8-40A5-BDD3-9A7FE6068F0B

Q37445933-1FE53202-23EA-4173-81FE-11923B97D190

Q37445933-22862AD0-2BA2-4027-A45A-EF2D72E16420

Q37445933-24EBE892-488C-4EB9-9274-BC7ED1AFBC0D

Q37445933-6D32BBA9-88BF-4A7D-8916-6D9A2D01C492

Q37445933-8BD2199F-71AB-4B91-AB33-B78ABE8F4A5F

Q37445933-9EDD0520-5358-4171-9A80-37979603F2EE

Q37445933-D3D1AB55-4F10-4320-B158-01565891FC82

Q37445933-D7ECB6CB-1D39-490A-8921-79C3E81B454F

Q37445933-EA7ACDEE-695C-4B60-87EE-21324EA7B3F1

P304

Q37445933-615CC823-B893-4324-9677-F79B680CE562

P31

Q37445933-A13A6442-55CD-4089-A176-BD9588D7F818

P356

Q37445933-BE10768E-2201-41AD-AEF8-903D41BF7192

P407

Q37445933-14D4C4D8-99B8-48A5-BCA4-18A6E62CE656

P433

Q37445933-94A8918C-A74B-4468-9F71-873C461B2933

P478

Q37445933-10F47174-1FB9-42E1-BFBA-C3EB390C4C4C

P577

Q37445933-80D8D440-8554-4FE8-821A-7FF4F42181FA

P698

Q37445933-BDD96A40-4B2A-4194-A6B2-425DE51A59CE

P932

Q37445933-156BA3A0-A2A1-4B05-9405-2E84C897F5AF

P356

P1433

British Journal of Haematology

P1476

Outcomes of MYC-associated lym ...... d trial intergroup SWOG S9704.

@en

P2093

Brad Kahl

http://www.w3.org/2001/XMLSchema#string

Deborah Marcellus

http://www.w3.org/2001/XMLSchema#string

Hongli Li

http://www.w3.org/2001/XMLSchema#string

James R Cook

http://www.w3.org/2001/XMLSchema#string

Jane N Winter

http://www.w3.org/2001/XMLSchema#string

John P Leonard

http://www.w3.org/2001/XMLSchema#string

Jonathan W Friedberg

http://www.w3.org/2001/XMLSchema#string

Lisa M Rimsza

http://www.w3.org/2001/XMLSchema#string

Michael Leblanc

http://www.w3.org/2001/XMLSchema#string

Patrick J Stiff

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.

Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma

Double-hit B-cell lymphomas.

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

P304

686-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14100

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27072903

http://www.w3.org/2001/XMLSchema#string

P932

5125530

http://www.w3.org/2001/XMLSchema#string